{"nctId":"NCT04824365","briefTitle":"Sodium Pyruvate Nasal Spray Treatment of COVID-19 Infection","startDateStruct":{"date":"2021-04-12","type":"ACTUAL"},"conditions":["COVID-19"],"count":30,"armGroups":[{"label":"Treatment of COVID-19 infected patients with a sodium pyruvate nasal spray","type":"EXPERIMENTAL","interventionNames":["Drug: Sodium Pyruvate"]},{"label":"Placebo control treatment of COVID-19 infected patients","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Saline"]}],"interventions":[{"name":"Sodium Pyruvate","otherNames":["N115"]},{"name":"Saline","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Individuals with a confirmed COVID-19 viral infection, as determined by a qualified laboratory test. A nasal swab or saliva test analyzed by qPCR for COVID19.\n2. Individuals who agree to abstain from sexual intercourse, or agree to use condoms or vaginal diaphragms or other devices designed to prevent contraception, during the entire course of the study\n\nExclusion Criteria\n\n1. Viral infections other than COVID-19.\n2. Clinically significant cardiac disease including uncontrolled congestive heart failure and unstable angina\n3. Pregnancy\n4. Females of child bearing potential age not on adequate contraception or lactating\n5. Subjects receiving systemic corticosteroid treatment within one month of Screening Visit\n6. Subjects Less than 18 years of age\n7. Hospitalization within last 6 months due to acute exacerbation of airway disease\n8. Subjects with a clinically significant abnormal chest x-ray within past 12 months\n9. Medication changes within one month of study entry\n10. Subjects who have participated in another investigation drug treatment study within the previous month.\n11. Subjects with a current history of alcohol or recreational drug abuse.\n12. Subjects who have taken dietary supplements containing pyruvate within 24 hours prior to the screening visit.\n\nInclusion of Women and Minorities Every attempt will be made to include all genders, and minorities that present with an active COVID-19 infection that are not exempted due to exclusion criteria.\n\n\\-","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"40 Years","stdAges":["ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Evaluate the Ability of Inhaled Nasal Sodium Pyruvate to Change COVID-19 Viral Titers.","description":"RT-PCR was used to assess viral titers from nasal swabs from COVID19 patients. Swabs were collected and tested every 2 days for 14 days.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.61","spread":"0.26"},{"groupId":"OG001","value":"6.57","spread":"0.24"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.67","spread":"0.26"},{"groupId":"OG001","value":"5.86","spread":"0.20"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.27","spread":"0.26"},{"groupId":"OG001","value":"5.18","spread":"0.21"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.88","spread":"0.31"},{"groupId":"OG001","value":"4.55","spread":"0.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.48","spread":"0.34"},{"groupId":"OG001","value":"4.11","spread":"0.20"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.18","spread":"0.24"},{"groupId":"OG001","value":"3.71","spread":"0.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.96","spread":"0.23"},{"groupId":"OG001","value":"3.35","spread":"0.34"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.34","spread":"0.11"},{"groupId":"OG001","value":"2.78","spread":"0.39"}]}]}]},{"type":"PRIMARY","title":"Evaluate the Ability of Inhaled Nasal Sodium Pyruvate to Affect SaO2 in COVID-19 Infected Patients.","description":"Percent SaO2 was measured every other day by clinic staff.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"95.73","spread":"0.96"},{"groupId":"OG001","value":"95.4","spread":"0.83"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"95.6","spread":"0.99"},{"groupId":"OG001","value":"95.73","spread":"0.59"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"95.67","spread":"0.82"},{"groupId":"OG001","value":"95.8","spread":"0.77"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"96.07","spread":"1.22"},{"groupId":"OG001","value":"96.43","spread":"0.76"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"96.93","spread":"1.03"},{"groupId":"OG001","value":"96.71","spread":"0.91"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"97.33","spread":"0.82"},{"groupId":"OG001","value":"97.21","spread":"0.97"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"97.53","spread":"0.83"},{"groupId":"OG001","value":"97.5","spread":"0.76"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"97.8","spread":"0.56"},{"groupId":"OG001","value":"97.57","spread":"0.76"}]}]}]},{"type":"SECONDARY","title":"Evaluate the Ability of Inhaled Nasal Sodium Pyruvate to Affect Fever in COVID-19 Infected Patients.","description":"To evaluate the ability of the N115 nasal spray to improve fever in COVID19 patients oral measurement of body temperature was assessed every morning and every evening for 14 days. Reported values are the average daily body temperature.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"99.72","spread":"0.35"},{"groupId":"OG001","value":"99.82","spread":"0.20"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100.47","spread":"0.43"},{"groupId":"OG001","value":"100.18","spread":"0.42"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100.12","spread":"0.22"},{"groupId":"OG001","value":"99.51","spread":"0.28"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100.09","spread":"0.42"},{"groupId":"OG001","value":"99.8","spread":"0.37"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100.05","spread":"0.36"},{"groupId":"OG001","value":"99.43","spread":"0.30"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"99.8","spread":"0.33"},{"groupId":"OG001","value":"99.37","spread":"0.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"99.47","spread":"0.29"},{"groupId":"OG001","value":"98.97","spread":"0.15"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"99.56","spread":"0.37"},{"groupId":"OG001","value":"99.3","spread":"0.15"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"99.39","spread":"0.28"},{"groupId":"OG001","value":"99.17","spread":"0.14"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"99.4","spread":"0.25"},{"groupId":"OG001","value":"99.21","spread":"0.39"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"99.53","spread":"0.28"},{"groupId":"OG001","value":"99.22","spread":"0.20"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"99.24","spread":"0.16"},{"groupId":"OG001","value":"99.05","spread":"0.13"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"99.17","spread":"0.12"},{"groupId":"OG001","value":"98.84","spread":"0.16"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"99.18","spread":"0.15"},{"groupId":"OG001","value":"98.91","spread":"0.13"}]}]}]},{"type":"SECONDARY","title":"Evaluate the Ability of Inhaled Nasal Sodium Pyruvate to Affect Body Aches in COVID-19 Infected Patients.","description":"Patients self reported the symptom in a patient log daily for 14 days. A Likert scale from 0-10 was used to rank the symptom severity, with 10 representing the most severe symptoms.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.4","spread":"2.67"},{"groupId":"OG001","value":"5.13","spread":"2.85"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.4","spread":"2.67"},{"groupId":"OG001","value":"5.13","spread":"2.85"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.4","spread":"2.67"},{"groupId":"OG001","value":"4.88","spread":"2.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.0","spread":"1.94"},{"groupId":"OG001","value":"4.75","spread":"2.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.9","spread":"1.79"},{"groupId":"OG001","value":"4.25","spread":"2.49"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.5","spread":"2.12"},{"groupId":"OG001","value":"4","spread":"2.56"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.3","spread":"2.21"},{"groupId":"OG001","value":"3.5","spread":"2.45"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.6","spread":"2.59"},{"groupId":"OG001","value":"3.25","spread":"2.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":"2.4"},{"groupId":"OG001","value":"3.125","spread":"2.42"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":"2.4"},{"groupId":"OG001","value":"3","spread":"2.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.4","spread":"2.22"},{"groupId":"OG001","value":"2.375","spread":"2.56"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.1","spread":"2.08"},{"groupId":"OG001","value":"2","spread":"2.39"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.6","spread":"2.27"},{"groupId":"OG001","value":"1.75","spread":"1.98"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":"1.83"},{"groupId":"OG001","value":"1.63","spread":"1.92"}]}]}]},{"type":"SECONDARY","title":"Evaluate the Ability of Inhaled Nasal Sodium Pyruvate to Affect Headaches in COVID-19 Infected Patients.","description":"Patients self reported the symptom in a patient log daily for 14 days. A Likert scale from 0-10 was used to rank the symptom severity, with 10 representing the most severe symptoms.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.25","spread":"3.1"},{"groupId":"OG001","value":"3.14","spread":"2.79"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.25","spread":"2.75"},{"groupId":"OG001","value":"3.14","spread":"2.79"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.75","spread":"2.22"},{"groupId":"OG001","value":"2.86","spread":"2.27"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.25","spread":"2.36"},{"groupId":"OG001","value":"2.71","spread":"2.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.25","spread":"2.22"},{"groupId":"OG001","value":"2.29","spread":"1.89"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.75","spread":"1.89"},{"groupId":"OG001","value":"2.14","spread":"2.04"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.75","spread":"2.50"},{"groupId":"OG001","value":"2.00","spread":"1.83"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.75","spread":"2.50"},{"groupId":"OG001","value":"1.86","spread":"1.95"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.50","spread":"2.38"},{"groupId":"OG001","value":"1.57","spread":"1.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.00","spread":"1.63"},{"groupId":"OG001","value":"1.29","spread":"1.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.00","spread":"1.36"},{"groupId":"OG001","value":"1.14","spread":"1.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.75","spread":"2.22"},{"groupId":"OG001","value":"1.00","spread":"1.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.75","spread":"1.71"},{"groupId":"OG001","value":"1.00","spread":"1.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.0","spread":"1.83"},{"groupId":"OG001","value":"1.00","spread":"1.00"}]}]}]},{"type":"SECONDARY","title":"Evaluate the Ability of Inhaled Nasal Sodium Pyruvate to Affect Chills in COVID-19 Infected Patients.","description":"Patients self reported the symptom in a patient log daily for 14 days. A Likert scale from 0-10 was used to rank the symptom severity, with 10 representing the most severe symptoms.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":"2.67"},{"groupId":"OG001","value":"3.75","spread":"1.67"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.25","spread":"2.55"},{"groupId":"OG001","value":"3.50","spread":"2.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.25","spread":"2.05"},{"groupId":"OG001","value":"3.50","spread":"2.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.38","spread":"2.33"},{"groupId":"OG001","value":"3.13","spread":"1.96"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.50","spread":"2.33"},{"groupId":"OG001","value":"2.75","spread":"1.91"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.00","spread":"2.00"},{"groupId":"OG001","value":"2.63","spread":"1.69"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.13","spread":"2.17"},{"groupId":"OG001","value":"2.25","spread":"1.28"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.25","spread":"2.12"},{"groupId":"OG001","value":"1.75","spread":"1.49"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.88","spread":"2.03"},{"groupId":"OG001","value":"1.38","spread":"1.30"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.63","spread":"1.92"},{"groupId":"OG001","value":"1.00","spread":"1.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.13","spread":"1.81"},{"groupId":"OG001","value":"0.75","spread":"1.04"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.88","spread":"1.89"},{"groupId":"OG001","value":"0.38","spread":"0.52"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.38","spread":"2.13"},{"groupId":"OG001","value":"0.38","spread":"0.52"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.38","spread":"2.13"},{"groupId":"OG001","value":"0.38","spread":"0.52"}]}]}]},{"type":"SECONDARY","title":"Evaluate the Ability of Inhaled Nasal Sodium Pyruvate to Affect Coughing and Sneezing in COVID-19 Infected Patients.","description":"Patients self reported the symptom in a patient log daily for 14 days. A Likert scale from 0-10 was used to rank the symptom severity, with 10 representing the most severe symptoms. The symptoms of both coughing and sneezing were assessed on the same Likert scale for this Outcome Measure.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.90","spread":"2.69"},{"groupId":"OG001","value":"4.45","spread":"2.16"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.70","spread":"2.58"},{"groupId":"OG001","value":"4.45","spread":"2.16"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.50","spread":"2.42"},{"groupId":"OG001","value":"4.18","spread":"2.44"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.40","spread":"1.78"},{"groupId":"OG001","value":"4.18","spread":"2.27"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.20","spread":"1.93"},{"groupId":"OG001","value":"3.64","spread":"2.16"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.10","spread":"2.02"},{"groupId":"OG001","value":"3.64","spread":"2.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.80","spread":"1.93"},{"groupId":"OG001","value":"3.55","spread":"2.16"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.70","spread":"2.0"},{"groupId":"OG001","value":"2.82","spread":"2.40"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.40","spread":"1.96"},{"groupId":"OG001","value":"2.73","spread":"2.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"190","spread":"1.52"},{"groupId":"OG001","value":"2.36","spread":"2.16"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.40","spread":"1.65"},{"groupId":"OG001","value":"2.09","spread":"2.17"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.40","spread":"1.65"},{"groupId":"OG001","value":"1.64","spread":"1.69"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.10","spread":"1.66"},{"groupId":"OG001","value":"1.45","spread":"1.44"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.10","spread":"1.66"},{"groupId":"OG001","value":"1.18","spread":"1.17"}]}]}]},{"type":"SECONDARY","title":"Evaluate the Ability of Inhaled Nasal Sodium Pyruvate to Affect Sore Throat in COVID-19 Infected Patients.","description":"Patients self reported the symptom in a patient log daily for 14 days. A Likert scale from 0-10 was used to rank the symptom severity, with 10 representing the most severe symptoms.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.71","spread":"2.29"},{"groupId":"OG001","value":"4.71","spread":"1.70"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.71","spread":"2.14"},{"groupId":"OG001","value":"4.71","spread":"1.70"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.57","spread":"1.81"},{"groupId":"OG001","value":"4.57","spread":"1.72"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.29","spread":"2.06"},{"groupId":"OG001","value":"4.57","spread":"1.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.14","spread":"2.04"},{"groupId":"OG001","value":"4.0","spread":"1.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.29","spread":"2.06"},{"groupId":"OG001","value":"3.86","spread":"1.77"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.14","spread":"2.12"},{"groupId":"OG001","value":"3.71","spread":"1.60"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.29","spread":"2.43"},{"groupId":"OG001","value":"3.00","spread":"2.31"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.86","spread":"2.12"},{"groupId":"OG001","value":"2.86","spread":"2.12"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.29","spread":"1.70"},{"groupId":"OG001","value":"2.57","spread":"2.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.00","spread":"1.91"},{"groupId":"OG001","value":"2.14","spread":"2.27"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.57","spread":"1.72"},{"groupId":"OG001","value":"1.71","spread":"1.60"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.86","spread":"1.46"},{"groupId":"OG001","value":"1.57","spread":"1.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.86","spread":"1.46"},{"groupId":"OG001","value":"1.29","spread":"1.60"}]}]}]},{"type":"SECONDARY","title":"Evaluate the Ability of Inhaled Nasal Sodium Pyruvate to Affect Congestions in COVID-19 Infected Patients.","description":"Patients self reported the symptom in a patient log daily for 14 days. A Likert scale from 0-10 was used to rank the symptom severity, with 10 representing the most severe symptoms.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.00","spread":"3.38"},{"groupId":"OG001","value":"5.00","spread":"3.56"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.00","spread":"2.83"},{"groupId":"OG001","value":"5.00","spread":"3.62"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.75","spread":"2.92"},{"groupId":"OG001","value":"4.90","spread":"3.63"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.50","spread":"2.39"},{"groupId":"OG001","value":"4.60","spread":"2.91"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.50","spread":"2.00"},{"groupId":"OG001","value":"4.10","spread":"2.85"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.50","spread":"2.00"},{"groupId":"OG001","value":"4.30","spread":"2.98"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.25","spread":"1.98"},{"groupId":"OG001","value":"3.70","spread":"2.67"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.31","spread":"2.30"},{"groupId":"OG001","value":"2.80","spread":"2.74"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.00","spread":"2.39"},{"groupId":"OG001","value":"2.60","spread":"2.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.88","spread":"1.73"},{"groupId":"OG001","value":"2.20","spread":"2.74"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.13","spread":"1.96"},{"groupId":"OG001","value":"1.60","spread":"2.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.50","spread":"1.31"},{"groupId":"OG001","value":"1.50","spread":"2.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.00","spread":"1.07"},{"groupId":"OG001","value":"0.60","spread":"1.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.25","spread":"1.28"},{"groupId":"OG001","value":"0.60","spread":"1.07"}]}]}]},{"type":"SECONDARY","title":"Evaluate the Ability of Inhaled Nasal Sodium Pyruvate to Affect Trouble Breathing in COVID-19 Infected Patients.","description":"Patients self reported the symptom in a patient log daily for 14 days. A Likert scale from 0-10 was used to rank the symptom severity, with 10 representing the most severe symptoms.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.08","spread":"3.73"},{"groupId":"OG001","value":"5.18","spread":"4.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.25","spread":"3.57"},{"groupId":"OG001","value":"5.18","spread":"4.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.00","spread":"3.28"},{"groupId":"OG001","value":"4.91","spread":"4.04"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.42","spread":"2.71"},{"groupId":"OG001","value":"4.27","spread":"3.47"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.17","spread":"2.55"},{"groupId":"OG001","value":"4.00","spread":"3.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.75","spread":"2.49"},{"groupId":"OG001","value":"4.18","spread":"2.99"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.67","spread":"2.35"},{"groupId":"OG001","value":"3.55","spread":"2.42"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.67","spread":"2.35"},{"groupId":"OG001","value":"3.00","spread":"1.90"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.92","spread":"2.31"},{"groupId":"OG001","value":"2.55","spread":"1.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.58","spread":"1.51"},{"groupId":"OG001","value":"2.00","spread":"1.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.17","spread":"1.27"},{"groupId":"OG001","value":"1.64","spread":"1.21"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.50","spread":"1.24"},{"groupId":"OG001","value":"0.91","spread":"0.83"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.25","spread":"1.06"},{"groupId":"OG001","value":"0.36","spread":"0.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.92","spread":"1.16"},{"groupId":"OG001","value":"0.27","spread":"0.47"}]}]}]},{"type":"SECONDARY","title":"Evaluate the Ability of Inhaled Nasal Sodium Pyruvate to Affect Fatigue in COVID-19 Infected Patients.","description":"Patients self reported the symptom in a patient log daily for 14 days. A Likert scale from 0-10 was used to rank the symptom severity, with 10 representing the most severe symptoms.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.43","spread":"1.51"},{"groupId":"OG001","value":"7.50","spread":"1.29"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.43","spread":"1.51"},{"groupId":"OG001","value":"7.50","spread":"1.29"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.00","spread":"1.91"},{"groupId":"OG001","value":"7.25","spread":"1.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.86","spread":"1.35"},{"groupId":"OG001","value":"7.00","spread":"1.41"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.57","spread":"1.72"},{"groupId":"OG001","value":"7.00","spread":"1.41"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.71","spread":"1.50"},{"groupId":"OG001","value":"6.50","spread":"2.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.57","spread":"1.72"},{"groupId":"OG001","value":"6.50","spread":"1.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.29","spread":"1.98"},{"groupId":"OG001","value":"6.50","spread":"1.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.43","spread":"1.90"},{"groupId":"OG001","value":"4.50","spread":"1.29"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.29","spread":"1.60"},{"groupId":"OG001","value":"4.25","spread":"1.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.57","spread":"1.51"},{"groupId":"OG001","value":"3.50","spread":"1.91"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.00","spread":"1.00"},{"groupId":"OG001","value":"3.50","spread":"1.91"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.57","spread":"1.27"},{"groupId":"OG001","value":"2.50","spread":"1.29"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.57","spread":"1.27"},{"groupId":"OG001","value":"2.25","spread":"1.26"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":15},"commonTop":[]}}}